In a detailed X post on Tuesday, Demis Hassabis, chief executive of Google DeepMind, called for the establishment of a new, independent “standards body” to oversee the release of frontier artificial‑intelligence models. The proposal, titled “A Framework for Frontier AI and the Dawning of a New Age,” draws inspiration from the Financial Industry Regulatory Authority (FINRA), suggesting a similar self‑regulatory structure for AI.

Proposed Structure and Process

According to Hassabis, “Frontier Labs would voluntarily share models with the Standards Body for review up to 30 days before release.” During this window, the body would conduct technical assessments, flag critical vulnerabilities, and recommend mitigation steps. Once the assessment protocol proves robust, it could be formalised, making compliance mandatory for any frontier model seeking entry into the U.S. market.

Shortcomings of Past Government Reviews

Recent ad‑hoc reviews of Anthropic’s “Mythos” and OpenAI’s “Sol” by U.S. agencies attracted criticism for lacking technical depth and operating behind opaque decision‑making curtains. Hassabis’s model seeks to shift those responsibilities to an independent organisation, backed by the government but financed and staffed by the AI industry itself, thereby marrying expertise with accountability.

Funding, Staffing, and Operational Model

Mirroring FINRA’s self‑regulatory approach, the proposed body would be funded by AI labs, staffed by open‑source advocates, industry technical experts, and possibly outsourced to specialized AI‑safety groups. This arrangement aims to keep the regulatory environment flexible enough to nurture rapid innovation while incentivising responsible conduct.

Implications and Challenges Ahead

Hassabis argues that this framework “is technically focused, while at the same time supporting innovation and incentivising responsible behaviour.” Should the risk profile of frontier models intensify, the standards body could be “ratcheted up” accordingly. While the idea has drawn interest, it also faces skepticism from both tech circles and the current administration, which has previously dismissed the notion of an “FDA for AI.” Nevertheless, the proposal could become a pivotal step toward a transparent, industry‑driven governance model for the most powerful AI systems.